Immunovant
IMVT
#3638
Rank
S$3.57 B
Marketcap
$21.03
Share price
-3.90%
Change (1 day)
-49.96%
Change (1 year)

Immunovant (IMVT) - Cash on Hand

Cash on Hand as of December 2024 : S$0.49 Billion

According to Immunovant's latest financial reports the company has S$0.49 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Immunovant - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-03-31S$0.85 B71.43%
2023-03-31S$0.50 B-25.14%
2022-03-31S$0.66 B23.91%
2021-03-31S$0.53 B276.44%
2020-03-31S$0.14 B
2018-12-31S$0.44 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.34 B-31.69%๐Ÿ‡บ๐Ÿ‡ธ USA